title: Adhesion molecules and transplantation.
abstract: OBJECTIVE
  Accessory adhesion molecules are thought to influence the first interaction between host leukocytes and graft vascular endothelial cells. Their role in transplantation is reviewed.
  
  
  CONCLUSIONS
  Adhesion molecules have been divided into three major families: the selectins, the integrins, and the immunoglobulin superfamily. Selectins are small proteins that mediate the first contact between stimulated endothelial cells and leukocytes. Integrins interact with cytoskeletal components of cells, presumably coordinating extracellular stimuli with cytoskeleton dependent actions, such as motility, shape change, and phagocytic responses. Members of the immunoglobulin superfamily are structurally homologous, although they do not necessarily share similar functions. They are involved in T-cell proliferation and intracellular events.
  
  
  METHODS
  Various groups of investigators have studied the influence and expression of adhesion molecules following transplantation. The authors of this article have reviewed and summarized the available literature.
  
  
  RESULTS
  Many different adhesion molecules are up-regulated during the rejection event. Treatment of transplant recipients with monoclonal antibodies against accessory molecules, such as leukocyte function associated antigen 1 (LFA-1) and intercellular adhesion molecule 1 (ICAM-1), has resulted in either a prolongation of transplant survival or the induction of tolerance in some models. Other interventions are under study.
  
  
  CONCLUSIONS
  By mediating the initial leukocyte/endothelial cell interactions, adhesion molecules may play an important role in graft rejection, mediation of infiltration into the graft, and dissemination of the antigenic message to the lymphoid tissues of the host. Future studies will have to deal not only with conceptualizing their function and mechanisms of action, but also with manipulating their interrelationships to the benefit of the graft recipient.
authors.affiliation: Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts.
authors.forename: U W
authors.initials: UW
authors.lastname: Heemann
authors.forename: S G
authors.initials: SG
authors.lastname: Tullius
authors.forename: H
authors.initials: H
authors.lastname: Azuma
authors.forename: J
authors.initials: J
authors.lastname: Kupiec-Weglinsky
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002448:Cell Adhesion / Q000276:immunology*; D015815:Cell Adhesion Molecules / Q000276:immunology* / Q000502:physiology; D005803:Genes, Immunoglobulin; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D014181:Transplantation Immunology
chemical_list: D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules